Mechanisms potentially contributing to the reduction in mortality associated with ticagrelor therapy

Journal of the American College of Cardiology

Volumn 57, Issue 6, 2011, Pages 685-687

  Schneider, David J ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

acute coronary syndrome; bleeding; coronary artery bypass surgery; platelet inhibition

Indexed keywords

CLOPIDOGREL; TICAGRELOR;

ACUTE CORONARY SYNDROME; BLEEDING; CORONARY ARTERY BYPASS SURGERY; HEMOSTASIS; HUMAN; MORTALITY; NOTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION INHIBITION; TREATMENT OUTCOME;

EID: 79551538970     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.11.016     Document Type: Editorial

References (17)

1. C. Held, N. senblad, and J.P. Bassand Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial J Am Coll Cardiol 57 2011 672 684
2. L. Wallentin, R.C. Becker, and A. Budaj Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
3. D. Capodanno, K. Dharmashankar, and D.J. Angiolillo Mechanism of action and clinical development of ticagrelor, a novel platelet ADP P2Y12 receptor antagonist Expert Rev Cardiovasc Ther 8 2010 151 158
4. P.A. Gurbel, K.P. Bliden, and K. Butler Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study Circulation 120 2009 2577 2585
5. S.D. Wiviott, E. Braunwald, and C.H. McCabe Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015 (Pubitemid 350106708)
6. S. Husted, R.F. Storey, R.A. Harrington, H. Emanuelsson, and C.P. Cannon Changes in inflammatory biomarkers in patients treated with ticagrelor or clopidogrel Clin Cardiol 33 2010 206 212
7. M. Hamon, E. Filippi-Codaccioni, J.W. Riddell, and O. Lepage Prognostic impact of major bleeding in patients with acute coronary syndromes A systematic review and meta-analysis EuroIntervention 3 2007 400 408
8. J.B. Lindsey, S.P. Marso, and M. Pencina Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) registry J Am Coll Cardiol Intv 2 2009 1074 1082
9. A.H. van Straten, M.W. Bekker, and M.A. Soliman Hamad Transfusion of red blood cells: the impact on short-term and long-term survival after coronary artery bypass grafting, a ten-year follow-up Interact Cardiovasc Thorac Surg 10 2010 37 42
10. P.J. Fielder, P. Hass, and M. Nagel Human platelets as a model for the binding and degradation of thrombopoietin Blood 89 1997 2782 2788
11. B. Thattaliyath, M. Cykowski, and P. Jagadeeswaran Young thrombocytes initiate the formation of arterial thrombi in zebrafish Blood 106 2005 118 124
12. D.J. Schneider, C.E. Holmes, H.S. Taatjes-Sommer, and B.E. Sobel Contributions of young platelets and of previously activated platelets to platelet reactivity in patients with coronary artery disease Thromb Res 121 2008 455 462
13. F.K. Keating, M.K. Fung, and D.J. Schneider Induction of platelet white blood cell (WBC) aggregate formation by platelets and WBCs in red blood cell units Transfusion 48 2008 1099 1105
14. Keating FK, Butenas S, Fung MK, Schneider DJ. Platelet-leukocyte interaction, leukocyte apoptosis and procoagulant activity in stored red blood cells. Transfusion 2010 Dec 3 [E-pub ahead of print]; doi: 10.1111/j.1537-2995. 2010.02950.x.
15. J.-A. Bjorkman, I. Kirk, and J.J. van Giezen AZD6140 inhibits adenosine uptake into erythrocytes and enhances coronary blood flow after local ischemia or intracoronary adenosine infusion (abstr) Circulation 116 2007 II28
16. R.F. Storey, K.P. Bliden, and S.B. Patil Incidence of dyspnea and assessment of cardiac and pulmonary function in patients with stable coronary artery disease receiving ticagrelor, clopidogrel, or placebo in the ONSET/OFFSET study J Am Coll Cardiol 56 2010 185 193
17. S.L. Hale, and R.A. Kloner Cardioprotection with adenosine-regulating agent, GP531: effects on no-reflow, infarct size, and blood flow following ischemia/reperfusion in the rabbit J Cardiovasc Pharmacol Ther 15 2010 60 67